A detailed history of Bank Of The West transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Bank Of The West holds 1,229 shares of VRTX stock, worth $570,944. This represents 0.04% of its overall portfolio holdings.

Number of Shares
1,229
Previous 1,267 3.0%
Holding current value
$570,944
Previous $367,000 3.54%
% of portfolio
0.04%
Previous 0.05%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Jan 31, 2023

SELL
$285.76 - $321.48 $10,858 - $12,216
-38 Reduced 3.0%
1,229 $354,000
Q3 2022

Oct 31, 2022

BUY
$273.83 - $305.53 $11,227 - $12,526
41 Added 3.34%
1,267 $367,000
Q2 2022

Aug 02, 2022

SELL
$234.96 - $292.55 $7,988 - $9,946
-34 Reduced 2.7%
1,226 $345,000
Q1 2022

Apr 22, 2022

SELL
$221.42 - $260.97 $8,413 - $9,916
-38 Reduced 2.93%
1,260 $329,000
Q4 2021

Jan 28, 2022

SELL
$177.01 - $223.45 $47,615 - $60,108
-269 Reduced 17.17%
1,298 $285,000
Q3 2021

Nov 09, 2021

SELL
$181.39 - $202.99 $11,064 - $12,382
-61 Reduced 3.75%
1,567 $284,000
Q2 2021

Aug 11, 2021

SELL
$187.49 - $221.1 $469,849 - $554,076
-2,506 Reduced 60.62%
1,628 $328,000
Q1 2021

May 10, 2021

SELL
$207.02 - $241.31 $67,074 - $78,184
-324 Reduced 7.27%
4,134 $888,000
Q4 2020

Feb 02, 2021

BUY
$207.01 - $276.09 $18,630 - $24,848
90 Added 2.06%
4,458 $1.05 Million
Q3 2020

Nov 05, 2020

SELL
$255.65 - $303.1 $566,520 - $671,669
-2,216 Reduced 33.66%
4,368 $1.19 Million
Q2 2020

Aug 10, 2020

SELL
$225.48 - $295.8 $71,928 - $94,360
-319 Reduced 4.62%
6,584 $1.91 Million
Q1 2020

May 08, 2020

SELL
$199.77 - $247.81 $202,167 - $250,783
-1,012 Reduced 12.79%
6,903 $1.64 Million
Q4 2019

Feb 10, 2020

SELL
$166.71 - $223.91 $10,502 - $14,106
-63 Reduced 0.79%
7,915 $1.73 Million
Q3 2019

Oct 28, 2019

BUY
$166.23 - $187.09 $56,518 - $63,610
340 Added 4.45%
7,978 $1.35 Million
Q2 2019

Jul 18, 2019

SELL
$164.61 - $190.37 $1,975 - $2,284
-12 Reduced 0.16%
7,638 $1.4 Million
Q1 2019

Apr 09, 2019

SELL
$163.73 - $194.7 $1.81 Million - $2.15 Million
-11,064 Reduced 59.12%
7,650 $1.41 Million
Q4 2018

Feb 07, 2019

BUY
$151.91 - $192.21 $1.4 Million - $1.77 Million
9,226 Added 97.24%
18,714 $3.36 Million
Q3 2018

Nov 02, 2018

BUY
$167.73 - $192.74 $99,967 - $114,873
596 Added 6.7%
9,488 $1.83 Million
Q2 2018

Jul 25, 2018

BUY
$145.72 - $169.96 $115,410 - $134,608
792 Added 9.78%
8,892 $1.51 Million
Q1 2018

May 08, 2018

BUY
$151.6 - $177.13 $197,686 - $230,977
1,304 Added 19.19%
8,100 $1.32 Million
Q4 2017

Feb 05, 2018

BUY
$137.28 - $155.55 $932,954 - $1.06 Million
6,796
6,796 $1.02 Million

Others Institutions Holding VRTX

About VERTEX PHARMACEUTICALS INC


  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $119B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Bank Of The West Portfolio

Follow Bank Of The West and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of The West, based on Form 13F filings with the SEC.

News

Stay updated on Bank Of The West with notifications on news.